[ Inglês] BTK Inhibitor Update From ASH 2017: What Are the Real-World Results?

Published on

Topics include: Treatments

How effective are BTK inhibitors for CLL? Do patients tolerate them well in the real-world? Our panel of CLL experts, including Dr. Anthony Mato from the Abramson Cancer Center, and Dr. Jennifer Brown from the Dana-Farber Cancer Institute, joined us at the American Society of Hematology (ASH) 2017 annual meeting to provide an update on the use of BTK inhibitors for CLL treatment. They discuss the treatment’s efficacy, toxicity profile, and the risk for cardiac issues.  Watch now to find out the latest news on BTK inhibitors.

This program is a Patient Empowerment Network program produced by PatientPower. We thank AbbVie, Inc. and Genentech for their support.

View more programs featuring , and

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

CLL Combination Therapy News From ASH 2017

What new combination therapies for CLL were presented at ASH 2017? Tune in to learn the latest with CLL expert Dr. Michael Choi.

Published:

CAR T-Cell Therapy Update From ASH 2017

Which CAR T-cell treatments are currently approved for cancer treatment? Watch now to hear an update from ASH 2017 with Dr. David Maloney.

Published:

ASH 2017 Daily Wrap: Day One

Patient Power founders Andrew and Esther Schorr are joined by MPN expert Dr. Naveen Pemmaraju, as they discuss research news from the 2017 ASH meeting.

Published:

Advertisement
Junte-se a nossa comunidade Cadastre-se para Eventos Leia nosso último blog
Advertisement

Page last updated on February 19, 2018